An emergency sign directs patients to the emergency room at the Kaiser Permanente San Diego Medical Center hospital in San Diego, Calif., on April 17, 2017. Mike Blake/Reuters
Americans enrolled in Medicare will pay about 50 percent less out of pocket in 2026 for some drugs including Pfizer and Bristol Myers Squibb’s blood thinner Eliquis and Merck & Co’s diabetes drug Januvia, a study in the five most populous U.S. states suggested.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
Read Full Article: https://www.theepochtimes.com/us/medicare-enrollees-to-pay-50-percent-less-for-some-drugs-in-2026-report-says-5960883/?utm_source=partner&utm_campaign=whatfinger
